Articles tagged with Memory T Cells
Researchers at Columbia University discovered that D-beta-hydroxybutyrate restores impaired brain function and protects against neurodegeneration in mice with Parkinson's disease. The study supports a critical role for mitochondrial defects in the progression of the disease.
A study challenges previous views on HIV-infected T cell lifespan, revealing that chronic immune activation drives high proliferation rates in memory T cells. HAART treatment improves long-lived T cell production, providing insight into the body's response to HIV infection.
Scientists have made a breakthrough in understanding the body's rejection of transplanted organs. Memory T cells were found to trigger rejection, even when other immune cells are disabled. This discovery may lead to new treatments that block memory T cell function and improve organ transplant success rates.
A new study by researchers at Beth Israel Deaconess Medical Center has identified gamma delta T cells as a crucial component of the immune response to tuberculosis infection. The study found that these white blood cells can develop memory and rapidly respond to infection, blurring the lines between innate and acquired immunity.
Researchers at Gladstone Institute discover HIV can infect naïve T cells, explaining how T-cell numbers diminish and leave the body susceptible to opportunistic infections. Infected naïve cells die, eliminating immune system's ability to respond to opportunistic infections characteristic of AIDS.
Scientists have developed a new marking system that allows them to visualize and track immune memory cells for the first time. This breakthrough has significant implications for vaccine development, organ transplantation, and the treatment of autoimmune diseases.
Researchers found that intense stimulation is required to create lasting memory T cells, which are crucial for killing HIV-infected or cancerous cells. This discovery may provide a solution to vaccine challenges in treating AIDS and cancer.